Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Caroline Vintergaard Ott |
Documentos disponibles escritos por este autor (2)
Refinar búsqueda
Structural changes in the hippocampus as a biomarker for cognitive improvements in neuropsychiatric disorders / Caroline Vintergaard Ott en European Neuropsychopharmacology, Año 2019 - Vol. 29 - No. 3 (Marzo)
[artículo]
Título : Structural changes in the hippocampus as a biomarker for cognitive improvements in neuropsychiatric disorders : A systematic review Tipo de documento: texto impreso Autores: Caroline Vintergaard Ott, Autor ; Claire Bergstrom Johnson, Autor ; Julian Macoveanu, Autor Fecha de publicación: 2021 Artículo en la página: pp. 319-329 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Biomarcador, Hipocampo, Trastornos neuropsiquiátricos, Desorden bipolar, Trastorno unipolar, Esquizofrenia Resumen: Cognitive impairments are a core feature of several neuropsychiatric disorders. A common biomarker for pro-cognitive effects may provide a much-needed tool to select amongst candidate treatments targeting cognition. Link: ./index.php?lvl=notice_display&id=26346
in European Neuropsychopharmacology > Año 2019 - Vol. 29 - No. 3 (Marzo) . - pp. 319-329[artículo] Structural changes in the hippocampus as a biomarker for cognitive improvements in neuropsychiatric disorders : A systematic review [texto impreso] / Caroline Vintergaard Ott, Autor ; Claire Bergstrom Johnson, Autor ; Julian Macoveanu, Autor . - 2021 . - pp. 319-329.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in European Neuropsychopharmacology > Año 2019 - Vol. 29 - No. 3 (Marzo) . - pp. 319-329
Palabras clave: Biomarcador, Hipocampo, Trastornos neuropsiquiátricos, Desorden bipolar, Trastorno unipolar, Esquizofrenia Resumen: Cognitive impairments are a core feature of several neuropsychiatric disorders. A common biomarker for pro-cognitive effects may provide a much-needed tool to select amongst candidate treatments targeting cognition. Link: ./index.php?lvl=notice_display&id=26346 The effect of erythropoietin on cognition in affective disorders -- Associations with baseline deficits and change in subjective cognitive complaints / Caroline Vintergaard Ott en European Neuropsychopharmacology, Año 2016 - Vol. 26 - No. 8 (Agosto)
[artículo]
Título : The effect of erythropoietin on cognition in affective disorders -- Associations with baseline deficits and change in subjective cognitive complaints Tipo de documento: texto impreso Autores: Caroline Vintergaard Ott, Autor ; Maj Vinberg, Autor ; Lars Vedel Kessing, Autor Fecha de publicación: 2021 Artículo en la página: pp. 1264-1273 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno depresivo, Trastorno bipolar, Epoetina Alfa, Deterioro cognitivo, Poner en pantalla Resumen: This is a secondary data analysis from our erythropoietin (EPO) trials. We examine (I) whether EPO improves speed of complex cognitive processing across bipolar and unipolar disorder, (II) if objective and subjective baseline cognitive impairment increases patients׳ chances of treatment-efficacy and (III) if cognitive improvement correlates with better subjective cognitive function,... Link: ./index.php?lvl=notice_display&id=26518
in European Neuropsychopharmacology > Año 2016 - Vol. 26 - No. 8 (Agosto) . - pp. 1264-1273[artículo] The effect of erythropoietin on cognition in affective disorders -- Associations with baseline deficits and change in subjective cognitive complaints [texto impreso] / Caroline Vintergaard Ott, Autor ; Maj Vinberg, Autor ; Lars Vedel Kessing, Autor . - 2021 . - pp. 1264-1273.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in European Neuropsychopharmacology > Año 2016 - Vol. 26 - No. 8 (Agosto) . - pp. 1264-1273
Palabras clave: Trastorno depresivo, Trastorno bipolar, Epoetina Alfa, Deterioro cognitivo, Poner en pantalla Resumen: This is a secondary data analysis from our erythropoietin (EPO) trials. We examine (I) whether EPO improves speed of complex cognitive processing across bipolar and unipolar disorder, (II) if objective and subjective baseline cognitive impairment increases patients׳ chances of treatment-efficacy and (III) if cognitive improvement correlates with better subjective cognitive function,... Link: ./index.php?lvl=notice_display&id=26518